Elimination of matrix and spectral interferences in the measurement of lead and cadmium in urine and blood by electrothermal atomic absorption spectrometry with deuterium background correction.
Direct measurement of lead and cadmium in blood and urine by electrothermal atomic absorption spectrometry with deuterium background correction (D2-AAS) is prone to severe matrix and spectral interferences. We overcame these effects by coating the L'vov platform with ammonium molybdate, reducing the atomization time, introducing a post-atomization cooling step, carefully selecting ashing and atomization temperatures, and using an appropriate procedure for matrix modification. To determine Pb and Cd in blood and urine, we used matrix-matched calibration curves. With the proposed procedure for sample preparation, both Pb and Cd in whole blood can be determined in the same diluted sample. Results obtained by D2-AAS correlate closely with those by Zeeman-corrected AAS. Detection limits (mean blank + 3 SDblank) for Pb in urine and blood were 4 micrograms/L. For cadmium, the detection limits were 0.4 and 0.1 micrograms/L for urine and blood analysis, respectively. Between-run CVs were less than 5.0%.
D'Haese
P C
PC
University of Antwerp, Department of Nephrology-Hypertension, Belgium.
Lamberts
L V
LV
Liang
L
L
Van de Vyver
F L
FL
De Broe
M E
ME
D002104:Cadmium / Q000097:blood / Q000378:metabolism* / Q000652:urine; D003903:Deuterium / Q000737:chemistry*; D006801:Humans; D007854:Lead / Q000097:blood / Q000378:metabolism* / Q000652:urine; D013054:Spectrophotometry, Atomic; D013696:Temperature
D002104:Cadmium; D007854:Lead; D003903:Deuterium